Company news
Sun Pharma Advanced Research Co. Ltd. (NSE:SPARC) news
Every Sun Pharma Advanced Research Co. Ltd. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Press Release Apr 30 2026
April 29, 2026
Press Release Feb 03 2026
February 3, 2026
Sun Pharma Advanced Research Co. Ltd. Press Release Feb 03 2026
February 2, 2026
Press Release Dec 31 2025
December 31, 2025
Press Release Dec 02 2025
December 2, 2025
Press Release Nov 20 2025
November 20, 2025
Press Release Mar 31 2025
March 31, 2025
Sun Pharma Advanced Research Co. Ltd. Press Release Mar 31 2025
March 30, 2025
Press Release Dec 17 2024
December 17, 2024
Sun Pharma Advanced Research Co. Ltd. Press Release Dec 17 2024
December 16, 2024
Press Release Dec 14 2024
December 14, 2024
Sun Pharma Advanced Research Co. Ltd. Press Release Dec 14 2024
December 13, 2024
Press Release Apr 10 2024
April 10, 2024
Sun Pharma Advanced Research Co. Ltd. Press Release Apr 10 2024
April 9, 2024
Press Release Jan 04 2024
January 4, 2024
Press Release Nov 02 2023
November 2, 2023
Sun Pharma Advanced Research Co. Ltd. Press Release Nov 02 2023
November 1, 2023
Press Release Oct 30 2023
October 30, 2023
Sun Pharma Advanced Research Co. Ltd. Press Release Oct 30 2023
October 29, 2023
Press Release Oct 19 2023
October 19, 2023
Sun Pharma Advanced Research : AGM Speech 2022-23
August 7, 2023
Press Release Jul 13 2023
July 13, 2023
Press Release Nov 18 2022
November 18, 2022
Sun Pharma Advanced Research : SEZABY™ (phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures
November 17, 2022
Press Release Nov 09 2022
November 9, 2022
Sun Pharma Advanced Research : Outcome of committee meeting
November 8, 2022
Press Release Sep 29 2022
September 29, 2022
Sun Pharma Advanced Research : AGM Speech 2021-22
September 22, 2022
Sun Pharma Advanced Research : FY 2021-22
August 30, 2022
Sun Pharma Advanced Research : Corporate Presentation
July 8, 2022
Press Release (Revised) Dec 10 2021
December 10, 2021
Press Release Dec 10 2021
December 10, 2021
Sun Pharma Advanced Research : Update on SPARC strategy and portfolio
December 9, 2021
Press Release Dec 08 2021
December 8, 2021
Sun Pharma Advanced Research : SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma
December 7, 2021
Press Release Dec 03 2021
December 3, 2021
Press Release Nov 26 2021
November 26, 2021
Sun Pharma Advanced Research : AGM Speech 2020-21
September 30, 2021
Press Release May 14 2021
May 14, 2021
Press Release Oct 14 2020
October 14, 2020
Press Release Sep 22 2020
September 22, 2020
Press Release (Revised) Aug 19 2020
August 19, 2020
Press Release Aug 19 2020
August 19, 2020
Sun Pharma Advanced Research : Press Release Sun Pharma and SPARC enter into a worldwide license agreement for SCD 044May 28, 2020
May 29, 2020
Sun Pharma Advanced Research : and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension
September 14, 2018